Evidence map›Paper›PMID 32252426›Full record

ArticleJournal of clinical medicine2020

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study.

Arturo Cuomo, Marco Cascella, Cira Antonietta Forte, Sabrina Bimonte, Gennaro Esposito, Stefano De Santis, Luigi Cavanna, Flavio Fusco, Mario Dauri, Silvia Natoli and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Effect of cancer treatment on sleep quality in cancer patients: A systematic review and meta-analysis of Pittsburgh Sleep Quality Index.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Opioid Misuse: A Review of the Main Issues, Challenges, and Strategies.International journal of environmental research and public health · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 1 country.

Arturo CuomoDivision of Anesthesia and Pain Medicine, Istituto Nazionale Tumori, IRCCS. Fondazione G. Pascale, 80131 Napoli, Italy.
Marco CascellaDivision of Anesthesia and Pain Medicine, Istituto Nazionale Tumori, IRCCS. Fondazione G. Pascale, 80131 Napoli, Italy.
Cira Antonietta ForteDivision of Anesthesia and Pain Medicine, Istituto Nazionale Tumori, IRCCS. Fondazione G. Pascale, 80131 Napoli, Italy.
Sabrina BimonteDivision of Anesthesia and Pain Medicine, Istituto Nazionale Tumori, IRCCS. Fondazione G. Pascale, 80131 Napoli, Italy.
Gennaro EspositoDivision of Anesthesia and Pain Medicine, Istituto Nazionale Tumori, IRCCS. Fondazione G. Pascale, 80131 Napoli, Italy.
Stefano De SantisPalliative Care and Oncologic Pain Service, S. Camillo-Forlanini Hospital, 00149 Rome, Italy.
Luigi CavannaDepartment of Oncology-Hematology, G. da Saliceto Hospital, 29121 Piacenza, Italy.
Flavio FuscoPalliative Home Care Unit, ASL 3, 16153 Genova, Italy.
Mario DauriDepartment of Anesthesiology and Resuscitation, II University of Rome, Tor Vergata, 00133 Roma, Italy.
Silvia NatoliDepartment of Anesthesiology and Resuscitation, II University of Rome, Tor Vergata, 00133 Roma, Italy.
Marco MaltoniPalliative Care Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.
Alessandro MorabitoMedical Oncology Unit, Istituto Nazionale Tumori, IRCCS. Fondazione G. Pascale, 80131 Napoli, Italy.
Rocco Domenico MediatiPalliative Care and Pain Therapy Unit, University Hospital Careggi, 50134 Firenze, Italy.
Vito LorussoUO Oncologia Medica, Istituto Tumori "G Paolo II", 70124 Bari, Italy.
Sandro BarniOncology Unit, ASST Bergamo Ovest, 24047 Treviglio, Italy.
Giampiero PorzioMedical Oncology Unit, San Salvatore Hospital, University of L'Aquila, 67100 L'Aquila, Italy.
Sebastiano MercadanteMain regional center for Pain Relief & Supportive Care, La Maddalena Cancer Center, 90146 Palermo, Italy.
Anna CrispoEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori, IRCCS. Fondazione G. Pascale, 80131 Napoli, Italy.
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversity of Rome Tor Vergata · ITAzienda Ospedaliera Treviglio · ITAzienda Ospedaliero-Universitaria Careggi · ITCarlo Forlanini Hospital · ITGuglielmo da Saliceto Hospital · ITIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITIstituto Tumori Bari · ITLa Maddalena · ITUniversity of L'Aquila · IT

Funding

Teva Pharmaceutical Industries C25608-CNS-40076
6 · The paper itself

Abstract

objectivesTo explore the effect of breakthrough cancer pain (BTcP) treatment on quality of sleep and other aspects of the health-related quality of life (HRQoL) in patients with cancer pain.

methodsIn an observational, multicenter, cohort study, cancer patients from palliative care units, oncology departments, and pain clinics and affected by BTcP were included. Enrolled patients were assessed at the four visits: T0 (baseline), T7, T14, and T28. Stable chronic background pain (numeric rating scale, NRS ≤ 4) during the whole study period was mandatory. BTcP was treated through transmucosal fentanyl. Three questionnaires were used to measure the HRQoL: EORTC QLQ-C15-PAL, Pittsburgh Sleep Quality Index (PSQI), and the Edmonton Symptom Assessment System (ESAS).

resultsIn 154 patients, the HRQoL showed a significant improvement for all physical and emotional characteristics in the EORTC QLQ-C15-PAL, except for nausea and vomiting (linear

conclusionsThis prospective investigation by an Italian expert group, has confirmed that careful management of BTcP induces a paramount improvement on the HRQoL. Because in cancer patients there is a high prevalence of BTcP and this severe acute pain has deleterious consequences, this information can have an important clinical significance.

Indexed as

breakthrough cancer paincancercancer-associated painhealth-related quality of lifesleep disorderstransmucosal fentanyl

Identifiers

PMID32252426
PMCPMC7230287
OpenAlexW3006281041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.